{
    "nct_id": "NCT03211065",
    "official_title": "The Use of 20% Subcutaneous Immunoglobulin Replacement Therapy in Patients With B Cell Non Hodgkin's Lymphoma With Humoral Immune Dysfunction After Treatment With Rituximab",
    "inclusion_criteria": "1. Diagnosis of B cell non-Hodgkin's lymphoma\n2. Medically stable\n3. Able to understand and willingness to sign a written informed consent\n4. Able to comply with study procedures\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Previously diagnosed primary immunodeficiency\n2. Additional immunosuppressive states\n3. Ongoing therapy with Ig replacement",
    "miscellaneous_criteria": ""
}